Your browser doesn't support javascript.
loading
Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016.
Ebrahimi, Hedyeh; Amini, Erfan; Pishgar, Farhad; Moghaddam, Sahar Saeedi; Nabavizadeh, Behnam; Rostamabadi, Yasna; Aminorroaya, Arya; Fitzmaurice, Christina; Farzadfar, Farshad; Nowroozi, Mohammad Reza; Black, Peter C; Daneshmand, Siamak.
Afiliação
  • Ebrahimi H; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Amini E; Uro-Oncology Research Center, Tehran University of Medical Sciences , Tehran , Iran.
  • Pishgar F; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Moghaddam SS; Uro-Oncology Research Center, Tehran University of Medical Sciences , Tehran , Iran.
  • Nabavizadeh B; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Rostamabadi Y; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Aminorroaya A; Uro-Oncology Research Center, Tehran University of Medical Sciences , Tehran , Iran.
  • Fitzmaurice C; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Farzadfar F; Students' Scientific Research Center, Tehran University of Medical Sciences , Tehran , Iran.
  • Nowroozi MR; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences , Tehran , Iran.
  • Black PC; Students' Scientific Research Center, Tehran University of Medical Sciences , Tehran , Iran.
  • Daneshmand S; Institute for Health Metrics and Evaluation and Department of Medicine, Division of Hematology, University of Washington , Seattle , Washington.
J Urol ; 201(5): 893-901, 2019 05.
Article em En | MEDLINE | ID: mdl-30676477
PURPOSE: Bladder cancer is among the leading causes of cancer death worldwide. Data on the bladder cancer burden are valuable for policy-making. We aimed to estimate the burden of bladder cancer by country, age group, gender and sociodemographic status between 1990 and 2016. MATERIALS AND METHODS: Data from vital registration systems and cancer registries were the input to estimate the bladder cancer burden. Mortality was estimated in an ensemble model approach, incidence was estimated by dividing mortality by the mortality-to-incidence ratio and prevalence was estimated using the mortality-to-incidence ratio as a surrogate for survival. We modeled the years lived with disability using disability weights of bladder cancer sequelae. Years of life lost were calculated by multiplying the number of deaths by age by the standard life expectancy at that age. Disability adjusted life-years were calculated by summing the years lived with disability and the years of life lost. Moreover, we also estimated the burden attributable to bladder cancer risk factors, smoking and high fasting plasma glucose using the comparative risk assessment framework of the Global Burden of Disease study. RESULTS: In 2016 there were 437,442 incident cases (95% UI 426,709-447,912) of bladder cancer with an age standardized incidence rate of 6.69/100,000 (95% UI 6.52-6.85). Bladder cancer led to 186,199 deaths (95% UI 180,453-191,686) in 2016 with an age standardized rate of 2.94/100,000 (95% UI 2.85-3.03). Bladder cancer was responsible for 3,315,186 disability adjusted life-years (95% UI 3,193,248-3,425,530) in 2016 with an age standardized rate of 49.45/100,000 (95% UI 47.68-51.11). Of bladder cancer deaths 26.84% (95% UI 19.78-33.91) and 7.29% (95% UI 1.49-16.19) were due to smoking and high fasting glucose, respectively, in 2016. CONCLUSIONS: Although the number of bladder cancer incident cases is growing globally, the age standardized incidence and number of deaths are decreasing, as mirrored by a decreasing smoking contribution.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Sistema de Registros / Causas de Morte / Anos de Vida Ajustados por Qualidade de Vida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Sistema de Registros / Causas de Morte / Anos de Vida Ajustados por Qualidade de Vida Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã